Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
US Stock MarketDetailed Quotes
BCYC Bicycle Therapeutics
- 9.300
- +0.220+2.42%
Close May 2 16:00 ET
- 9.300
- 0.0000.00%
Post 16:00 ET
644.06MMarket Cap-2.94P/E (TTM)
9.550High9.130Low192.62KVolume9.440Open9.080Pre Close1.80MTurnover0.53%Turnover RatioLossP/E (Static)69.25MShares28.67052wk High0.87P/B337.81MFloat Cap6.10052wk Low--Dividend TTM36.32MShs Float62.075Historical High--Div YieldTTM4.62%Amplitude6.100Historical Low9.352Avg Price1Lot Size
About Bicycle Therapeutics Company
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
Company Profile
SymbolBCYC
Company NameBicycle Therapeutics
Listing DateMay 23, 2019
Issue Price14.00
Founded2009
CEODr. Kevin Lee, M.B.A.,PhD
MarketNASDAQ
Employees305
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressGranta Park Great Abington,Portway Building,Blocks A & B
CityCambridge
ProvinceCambridgeshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCB21 6GS
Phone44-1223-261503
Company Executives
- Name
- Position
- Salary
- Dr. Kevin Lee, M.B.A.,PhD
- Director and Chief Executive Officer
- 4.86M
- Travis Thompson
- Chief Accounting Officer
- --
- Dr. Eric Westin, M.D.
- Chief Medical Officer
- --
- Alethia Young
- Chief Financial Officer
- 1.47M
- Alistair Milnes
- Chief Operating Officer
- 2.59M
- Dr. Michael Skynner, PhD
- Chief Technology Officer
- --
- Dr. Michael Charles Ferguson Hannay, D.Sc.
- Chief Product and Supply Chain Officer
- 2.37M
- Jim MacDonald-Clink
- Senior Vice President and Head of Business Development
- --
- Pierre Legault, C.P.A.,M.B.A.
- Chairman of the Board
- 906.61K
- Dr. Fabrice Andre, M.D.,PhD
- Director
- --
- Richard N. Kender, M.B.A.
- Independent Director
- 374.60K
- Dr. Felix J. Baker,PhD
- Independent Director
- 658.32K
- Dr. Alessandro Riva, M.D.
- Independent Director
- --
- Sir Greg Winter, F.R.S.
- Independent Director
- 327.72K
- Janice Bourque, M.B.A.
- Independent Director
- 343.44K
- Stephen Sands
- Independent Director
- 711.92K
- Dr. Jose-Carlos Gutierrez-Ramos, PhD
- Independent Director
- 342.18K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
